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Background: Nanoemulsions consist of very stable nanodroplets of oil dispersed in an aqueous 
phase, typically below 300 nm in size. They can be used to obtain a very fine, homogeneous 
dispersion of lipophilic compounds in water, thus facilitating their handling and use in nano-
medicine. However, the drawback is that they are suspended in an aqueous media. This study 
proposes a novel technique for drying lipid nanoemulsion suspensions to create so-called Trojan 
particles, ie, polymer microparticles (around 2 µm) which very homogeneously “entrap” the 
nano-oil droplets (around 150 nm) in their core.
Methods: Microencapsulation of the nanoemulsions was performed using a spray-drying process 
and resulted in a dried powder of microparticles. By using a low-energy nanoemulsification method 
and relatively gentle spray-drying, the process was well suited to sensitive molecules. The model 
lipophilic molecule tested was vitamin E acetate, encapsulated at around 20% in dried powder.
Results: We showed that the presence of nanoemulsions in solution before spray-drying had 
a significant impact on microparticle size, distribution, and morphology. However, the process 
itself did not destroy the oil nanodroplets, which could easily be redispersed when the powder 
was put back in contact with water. High-performance liquid chromatography follow-up of the 
integrity of the vitamin E acetate showed that the molecules were intact throughout the process, 
as well as when conserved in their dried form.
Conclusion: This study proposes a novel technique using a spray-drying process to microen-
capsulate nanoemulsions. The multiscale object formed, so-called Trojan microparticles, were 
shown to successfully encapsulate, protect, and release the lipid nanodroplets.
Keywords: nanoemulsions, microparticles, Trojan particle, spray-drying, low-energy emulsi-
fication, vitamin E acetate
Introduction
Microencapsulation processes are generally used for both isolating and protecting 
sensitive substances or bioactive molecules and facilitating their controlled release.1 The 
formulation of microparticles is generally tailored to suit the target   administration route. 
Microparticles can be built with a core/shell structure composed of two   materials, ie, 
so-called “core materials” and “wall materials”. Active ingredients are either entrapped 
in the core materials, or form the core material itself, enclosed and protected by the 
wall material. The different formulation processes used to produce microparticles 
are divided into three groups, 1) chemical methods, eg, polymerization or interface 
polycondensation; 2) physicochemical methods, such as coacervation, solvent diffusion, 
solvent evaporation, phase separation, or rapid expansion of supercritical fluids; and 
3) physicomechanical methods, including spray-drying, fluidized-bed technology, 
or pan coating.2 In this paper, we focus on the third group of methods and notably International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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on use of the spray-drying process in the formulation of 
microparticles. Spray-drying is a widely used technology 
for microencapsulation in the food and pharmaceutical 
  industries. The process rapidly converts a liquid (which can be 
a solution, a suspension, or an   emulsion) into a dried powder. 
Core materials, homogeneously solubilized or dispersed in 
an aqueous media, are sprayed in contact with a hot gas flux. 
The sprayed droplets are still quite small, ranging from a few 
to a few hundred micrometers, thus developing a large air/
water interface area, resulting in effective heat transfer. As 
a result, the droplets are rapidly evaporated and dehydrated 
to form dried solid particles. The drying process is complete 
when the temperature of the particle is equal to that of the 
air.3 At this point, the active ingredients appear homogenously 
dispersed in the matricial, dried, microparticulate structure.4 
Spraying and drying the particles is a rapid process, per-
formed within a few seconds. It is this speed that makes the 
process suitable for use with sensitive or thermosensitive 
compounds without resulting in their degradation. When this 
process is performed with biodegradable and biocompat-
ible wall materials, and with adapting the particle sizes and 
densities to the administration route, spray-drying has been 
shown to be suitable for the inhalation route5,6 and intraocular 
administration.7 The solid forms generated can also be used 
to make tablets or capsules for oral administration, enhanc-
ing intestinal absorption and bioavailability. The nature of 
the solid formed helps increase the stability of compounds 
liable to oxidize in solution.
The spray-drying process produces relatively monodis-
persed particles with high encapsulation rates. Such micro-
metric systems present many advantages for pharmaceutical 
applications, such as easy manipulation and administration 
of the microparticles, for instance, and reduced clearance 
after subcutaneous or intraocular administration. However, a 
major disadvantage is their low penetration and diffusion in 
the tissues. To counter this problem, these microsized carriers 
encapsulate the nanoparticles capable of doing the job. These 
multiscaled systems are known as “Trojan” particles.7
When dried or in suspension, nanoparticles are not usable 
due to their low stability, aggregation, and hydrolysis in 
water. Their manipulation is greatly improved when encap-
sulated in the aforementioned Trojan systems. However, to 
date, only recent work proposes such formulations, using only 
polymeric nanoparticles.7–9 Although used as drug carriers, 
these polymeric nanoparticles present ongoing drawbacks 
due to the polymers themselves, which limit the drug encap-
sulation rates or leave polymeric residues in living tissues. 
The innovative concept of our work here is the creation of 
Trojan microparticles by spray-drying and encapsulation, 
not of polymeric nanoparticles but of nanoemulsions, which 
are fundamentally different systems. For pharmaceutical 
applications, nanoemulsions undoubtedly present numerous 
advantages in comparison with polymeric nanoparticles. 
For thermodynamic reasons, nanoemulsions prove to be 
extremely stable systems not only in suspension before spray-
drying, but also when the droplets are conserved through the 
process in water after dissolution of the   powder. The core 
of the droplet is often only made up of active ingredients 
(as is the case here), and thus the encapsulation rates and 
yields need to be a few orders of magnitude higher than for 
polymeric nanoparticles. For instance, Gomez-Gaete et al7 
encapsulated bioactive hydrophobic molecules of dexametha-
sone at nanoparticle encapsulation rates as low as 0.7%, and 
when the optimized solubilization of lipophilic compounds in 
oils increased, this rate and the direct emulsification of liquid 
lipids gave a full encapsulation of 100%. Such innovative 
Trojan particles also provide solutions for drying lipids or 
lipophilic bioactive molecules, and their nanoscaled formu-
lation increases and optimizes their bioavailability at the 
administration site. The major potential problem concerning 
microencapsulation of nanoemulsions, which we propose to 
address here, is conservation of the nanoemulsion structure 
and size distribution throughout the spray-drying process.
Nanoemulsions are generally defined as oil-in-water 
emulsion droplets, with a size ranging in the nanometric 
scale, typically 20–300 nm.10–12 Owing to their very small 
size, nanoemulsions have great stability for up to several 
months. The reasons for this stability are well documented in 
the literature,13–15 and originate in the unlikeliness of the drop-
lets to flocculate and coalesce. The only process of destabili-
zation is by Ostwald ripening. As a result, nanoemulsions can 
be used as a new tool for chemical and pharmaceutical appli-
cations, for instance providing a homogeneous dispersion of 
otherwise poorly soluble materials in water.   Nanoemulsions 
can be used as nanocarriers for drugs or contrast agents in the 
applications of targeting and controlled delivery. As regards 
the formulation processes for nanoemulsions, they can be 
divided into two groups, ie, high-energy and low-energy 
methods.13,14 High-energy methods use specific devices to 
form nanoemulsions, such as high-pressure homogenizers or 
ultrasound generators, whereas low-energy methods make 
the most of the intrinsic physicochemical properties of the 
components in the formulation to attain the nanometric 
range. In this case, nanoemulsions are formed spontaneously 
at room temperature.14 In our work, we have chosen to use 
low-energy methods, which are also both solvent-free and International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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polymer-free, for the generation of a definitively stable oil 
suspension dispersed in an aqueous phase.13–15
It is worth noting the many studies done on microencap-
sulating of emulsions using spray-drying.16–22 However, the 
objectives and scope of these published works are restricted 
to the drying of oily or fatty species, and do not deal with 
the conservation of the structure (eg, size) of the dispersed 
system or emulsified forms. That is precisely why these 
studies only concern conventional “macro emulsions” (ie, 
with a mean diameter of over 1 µm). Recent works have 
reported very efficient methods obtaining up to 90% of oil 
content in the dried powder.23 However, the emulsion droplet 
size plays an important role in the encapsulation efficiency 
during spray drying,16–18 ie, the smaller the size of the encap-
sulated emulsion, the more efficient the encapsulation. In 
this respect, the microencapsulation of nanoemulsions can 
further enhance the result without using specific interface 
crosslinking technology.23
Returning to the main objective, ie, the formulation of 
Trojan particles, our aim is to conserve the nanometric scale 
of the encapsulated droplets entrapped in the microparticles 
and to ensure their delivery, with resolubilization of the dried 
microparticle powder in water. In this work, we present a 
new methodological approach showing microencapsula-
tion of nanoemulsions. This should open new doors for the 
application of these simple and promising nanoparticulate 
systems. Low-energy nanoemulsification methods performed 
at room temperature, associated with the gentle process of 
spray-drying, make the whole formulation process suitable 
for encapsulation of sensitive molecules. In this study, we 
used a formulation with vitamin E acetate as the model lipo-
philic molecule to be encapsulated. This molecule constitutes 
the hydrophobic phase of the formulation and, consequently, 
the nanoemulsion core was made up exclusively of vitamin E 
acetate. The sample characterization was obtained by scan-
ning electron microscopy (SEM), and the particle size dis-
tributions were worked out by analyzing the SEM pictures, 
thus allowing a quantitative comparison of the powders. The 
microencapsulation process was first evaluated as a function 
of the various formulation parameters, such as the nature of 
the wall materials and the concentration in solution before 
spray-drying. These preliminary results subsequently allowed 
us to optimize the microencapsulation of a vitamin E acetate 
nanoemulsion. A number of biodegradable polymers were 
evaluated for use as wall materials in the process, namely, 
gum arabic, whey protein, polyvinyl alcohol, modified 
starches, maltodextrin, hydroxypropyl beta cyclodextrins, 
and pregelatinized hydroxypropyl pea starch. The stability 
of the nanoemulsions was controlled throughout the process 
by dynamic light scattering, and the integrity and stability of 
vitamin E acetate molecules was followed for 3 months using 
high-performance liquid chromatography (HPLC).
Methods and materials
Materials
Vitamin E acetate (DL-alpha-tocopheryl acetate) was pur-
chased from Sigma (St Louis, MO). Nonionic surfactants 
from BASF (Ludwigshafen, Germany), ie, Cremophor 
ELP® (polyoxiethylated-35 castor oil, hydrophilic–lipophilic 
balance approximately 12–14) were kindly provided by 
Laserson (Etampes, France), and used as received. The wall 
materials selected were gum arabic (CNI Colloides Naturels 
International, Rouen, France), whey protein (Davisco Foods 
International Inc, Eden Prairie, MN), Cleargum® CO 03 
(modified starch, Roquette, Lestrem, France), Glucidex® IT 
12 (maltodextrin, DE 12, Roquette), polyvinyl alcohol (PVA, 
Sigma), Kleptose® HPB Parenteral Grade (hydroxypropyl 
beta cyclodextrins, Roquette), Nutriose® FB 06 (modified 
starch, Roquette), and Lycoat® RS 780 (pregelatinized 
hydroxypropyl pea starch, Roquette). Finally, Ultrapure 
water was obtained using the MilliQ® filtration system 
(  Millipore, Saint-Quentin-en-Yvelines, France).
sample preparation
The samples were composed of nanoemulsions dispersed in 
an aqueous solution to dissolve the wall materials. Vitamin E 
acetate nanoemulsions were selected as model suspensions 
with a controllable size and polydispersity. The size range 
chosen was suited for microencapsulation. Nanoemulsions 
were formulated according to the low-energy emulsifica-
tion process described elsewhere.14 In short,   nanoemulsion 
droplets were spontaneously formed after bringing the two 
phases into contact. The first was composed of vitamin E 
acetate (the oily phase) plus the hydrophilic surfactant, both 
totally miscible in each other and gently homogenized at 
room temperature, and the second phase was pure water. 
Once these two liquid phases were mixed, the hydrophilic 
species were immediately solubilized by the aqueous 
phase, inducing the demixing of the oil (through spinodal 
decomposition) in the form of nanometric emulsion drop-
lets. Surfactants immediately stabilized the nanoemulsion 
droplets formed. Vitamin E acetate was chosen as a model 
oily phase, mixed with the nonionic surfactants, and then 
brought into contact with the aqueous phase, thus generating 
nanoemulsions. The spontaneous emulsification processes 
were characterized, as described previously,14 by following International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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the impact of the surfactant oil weight (SOW) ratio (wsurfactant/
[wsurfactant + woil] × 100) on both the hydrodynamic diameter 
and polydispersity index. The optimized formulation is a 
compromise between nanoemulsions presenting a good 
monodispersity, a size in the nanometric range, and the 
lowest possible amount of surfactant. The water added for 
the generation of nanoemulsions influences neither their 
physicochemical properties nor their size and polydisper-
sity index. Thus, the SOW ratio was fixed at 40% for all the 
formulations ([wsurfactant + woil]/[wsurfactant + wwater + woil] × 100). 
The size distribution and polydispersity of the nanoemulsions 
were assessed by dynamic light scattering using a Malvern 
Nano ZS® instrument (Malvern, Orsay, France). A helium-
neon laser (4 mW) was operated at 633 nm with the scatter 
angle fixed at 173°, and the temperature was maintained at 
25°C. The polydispersity index is a measure of the broadness 
of the size distribution derived from the cumulative analysis 
of dynamic light scattering. For a single Gaussian popula-
tion with standard deviation σ, and mean size xPCS, then the 
polydispersity index = σ2/x2
PCS is the relative variance of the 
distribution. The polydispersity index indicates the quality 
of the dispersion, from values lower than 0.1 for accept-
able measurements and good quality colloidal suspensions, 
to values close to 1 for poor quality samples, either with 
droplet sizes out of the colloidal range or with a very high 
polydispersity. Measurements were performed in triplicate, 
before and after the spray-drying process (filtered at 0.45 µm 
in the above case).
As regards the polymers used as wall materials, these 
were dissolved and swelled in ultrapure water 1 day prior to 
performing the experiments. The amount of wall material and 
its impact on the spray-dried particles was studied, as were 
the respective proportions of core and wall   materials which 
also appear to be an important parameter of the   formulation. 
These parameters were studied and optimized in order to 
incorporate the highest possible amount of oil with the dried, 
powdery aspect of the samples. The wall material solution 
was incorporated in the nanoemulsions of vitamin E acetate 
under stirring until a homogenous suspension was obtained.
spray-drying
The liquid suspensions were atomized into powders by the 
Büchi Mini Spray dryer B-290 (Flawil, Switzerland). The 
two-fluid nozzle dispersed the liquid suspensions into thin 
droplets, which were heated in the drying chamber. The 
droplets were instantly transformed into a dry powder. The 
speed of the process is acknowledged as being well suited to 
the spray-drying of sensitive or thermosensitive molecules. 
The operational conditions were as follows: aspiration 
rate 100%; inlet temperature 150°C; and solution feed rate 
10 mL/minute. The spray-dried powders were kept at room 
temperature in a closed flask.
scanning electron microscopy  
and size distributions
The size distribution and morphology of the spray-dried 
microparticles were evaluated by SEM (Philips XL20, 
  University of Strasbourg; Philips, Amsterdam, the 
  Netherlands). The specimen was fixed on a carbon support, 
coated with a palladium layer, and analyzed at 20 kV . The 
particle size distributions were analyzed from SEM micro-
graphs using a software-assisted method previously devel-
oped in our laboratory and already described elsewhere.24 The 
exact number of particles and their diameters were calculated 
from raw images, even for agglomerated particles. Hence, 
even if particles form aggregates, our method isolates each 
particle from the rest and defines its surface area, thus allow-
ing individual identification and disclosing the particle size 
distribution. A log-normal extrapolation was applied, with 
a probability density function of the form f (x; µ, σ) = exp 
(-[ln x - µ]2/2σ2)/(xσ[2π]1/2) (where µ and σ are the mean 
and standard deviation, respectively), thus making it pos-
sible to do a quantitative comparison of the SEM pictures 
and consequently enabling us to compare the spray-dried 
samples. The powders are formulated after carefully selecting 
a wall material/nanoemulsion ratio where no aggregates are 
formed so that the sample remains in powdered form even 
after drying. For conventional imaging in SEM, the sample 
needs to be fixed on a carbon support followed by coating 
with a conductive metallic layer, which makes the particles 
appear as if they are aggregated. However, the advantage 
of the software used for analyzing the size distribution lies 
in its ability to distinguish single particles even when they 
look aggregated. The originality of this approach lies in the 
possibility of quantitative analysis of the SEM pictures and 
thus of sample comparison. Each specimen of wall material 
encapsulating the nanoemulsions was spray-dried twice and 
the SEM measurements for each one were performed on three 
distinct SEM carbon supports. For each given experiment, 
a representative picture of the SEM results obtained was 
selected and reported in figures accompanying this paper.
stability study of vitamin e acetate  
in microparticles using hPLc
HPLC was used (Pump LC-126, detector LC-168, and 
  injector LC-508; Beckman-Coulter, Fullerton, CA) to follow International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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the stability and integrity of vitamin E acetate encapsulated 
in the spray-dried microparticles. The operational condi-
tions were defined as: stationary phase, column C8, length 
0.125° m, ϕ 4.0° mm (CC125/4 Lichrospher 100-5 RP-8; 
Macherey-Nagel, Düren, Germany); mobile phase, a mixture 
of 50 vol of acid aqueous phase (pH 2.3) and 950 vol of a 
mixture of 85% methyl alcohol and 15% isopropanol; flow 
rate 1.2 mL/minute; and a spectrophotometer operated at 
285 nm and injection volume 20 µL. The reference samples 
of vitamin E acetate were selected at a concentration of 
89 µg/mL.
Quantification of the vitamin E acetate trapped in the 
spray-dried microparticles was performed by collecting an 
amount of powder with a vitamin acetate content identical 
to that of the reference sample. The powder was then dis-
solved in the mixture of water and isopropanol. However, in 
accordance with the wall material properties, different ratios 
between water and isopropanol were used, adapted to the 
wall materials. The amount of vitamin E acetate was deter-
mined at initial time (ie, immediately after the spray-drying 
process) and then once a week for each wall material over 
3 months. Each specimen of wall material was spray-dried 
twice and the HPLC measurements for each powder were 
carried out in triplicate.
Results and discussion
Pure wall material microparticles
First, all the different wall materials were individually 
spray-dried in order to evaluate their potential influence on 
the spray-drying process and on the microparticle proper-
ties, ie, size, polydispersity, and morphology. The samples 
were spray-dried at 15 wt% in water before processing 
(a representative concentration). The SEM pictures are 
presented in Figure 1, including the quantitative study of 
the size maxima and standard deviation values. These latter 
values are reported in Figure 2.
The results are not only significant for size distribution 
and polydispersity, but also for particle shape and morphol-
ogy, which are closely linked to the interface properties of 
the compounds and to the spray-drying process. The first 
observation shows that the microparticle sizes are quite small, 
generally 1–4 µm. Furthermore, fluctuations of the maxima 
between different species are relatively reduced and not sig-
nificantly different. However, differences do exist, and could 
be due to the surfactant properties of the polymers, ie, gum 
arabic, whey protein, maltodextrin, and polyvinyl alcohol, 
giving rise to smaller particles, whereas Kleptose, Nutriose, 
Cleargum, and Lycoat produced bigger ones.
The SEM pictures reveal significant differences in 
particle morphology. Although the samples appear glob-
ally homogeneous regardless of the materials used and 
the microparticles show smooth surfaces and spherical 
geometry, some of them (eg, Figures 1B, 1C, 1D, 1F, and 
1G) show intense invaginations, with a shape resembling a 
“deflated ball”. To explain this result, an interesting parallel 
can be drawn between these deflated shapes and the global 
microparticulate sizes, in that the deflated shapes tend to 
correspond to the bigger particles. This is understandable 
because before drying all the wall material concentrations 
in water were the same and the droplets began to dry at 
their periphery. Thus, the formulations producing bigger 
sprayed droplets preferentially generate microparticles with 
an “empty” core, with a “deflated ball” morphology. This is 
clearly illustrated by the hydroxypropyl beta cyclodextrin 
particles (Kleptose) in Figure 1C, in which the bigger speci-
mens have shapes with very thin shells. These particular 
morphologies appear linked to the size of the sprayed drop-
lets, (ie, after spraying and before drying) and thus to the 
surface properties of the wall material solutions. Conversely, 
polyvinyl alcohol, known for its surfactant properties, forms 
spherical microparticles (Figure 1H). The picture also 
shows the presence of polymer “wires” that physically link 
the particles, their formation being influenced by interface 
phenomena and low surface tensions.
Influence of wall material concentration
This series of experiments was designed to observe the effect 
of the polymer concentration in the solution on the proper-
ties and morphology of the spray-dried microparticles. We 
thus studied the representative case of gum arabic solutions 
at 5, 10, 15, 20, and 30 wt%. The results are presented in 
Figure 3, including the quantitative study of the size maxima 
and standard deviation values. Sizes and standard deviations 
appear very similar in all the concentrations, ranging from 1.5 
and 2.0 µm, with standard deviations from 0.8 and 1.6 µm. 
However, there is a significant difference in the samples 
as regards global aspect, particle shape, and homogeneity. 
The higher the polymer concentration, the larger the size 
distribution, reaching huge particle sizes larger than 10 µm 
(shown in Figures 3D and 3E), which are in fact not visible 
in the statistical analysis because their proportions within 
the whole population are very small. This is probably due 
to the higher viscosity of the suspension, which increases 
with the concentration. Accordingly, the representative wall 
material concentration of 15 wt% was chosen for the rest of 
the experiments.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 1 Scanning electron micrographs of the powders of spray-dried pure wall material microparticles. The wall material concentration in water before processing is fixed 
at 15 wt%. (A) whey protein, (B) gum arabic, (C) Kleptose®, (D) Nutriose®, (E) maltodextrin, (F) cleargum®, (G) Lycoat®, and (H) polyvinyl alcohol. scale bar 10 µm.
Vitamin e acetate nanoemulsions
As described in the Methods section, the nanoemulsification pro-
cess is characterized by studying the influence of the surfactant-
to-oil ratio on the size and polydispersity of the nanoemulsions. 
These results are reported in Figure 4. The general trend, 
as expected and found with various other systems,14 shows 
a lowering of the droplet size and polydispersity index as 
the amount of surfactant is increased (ie, an increase of the 
surfactant-to-oil ratio). The first results highlight the efficiency 
of the nanoemulsification process: They are all the more 
significant because the formulation proposed here uses only 
vitamin E acetate as a hydrophobe, totally substituting any oily 
compounds generally used in these spontaneous emulsification 
processes (eg, oleic macrogols or triglycerides). Nanoemul-
sions with relatively monodispersed droplets (polydispersity 
index , 0.2), with dh = 189 nm, are obtained from a surfactant 
to oil ratio of 20%. With a surfactant to oil ratio of 40%, the 
droplet size falls to below 100 nm. In order to ensure efficient 
nanoemulsion encapsulation of the spray-dried microparticles, 
the present proof of concept study used nanodroplets below 
100 nm. Hence, the chosen value was a surfactant to oil of 
40% (indicated with the arrow in Figure 4), giving rise to 
nanoemulsions exhibiting a hydrodynamic diameter dh of 
84 nm and a polydispersity index of 0.11.
Microencapsulation of nanoemulsions
The production of dried microparticles to entrap the oily 
nanoemulsion droplets was performed, as described earlier, 
by spray-drying the nanoemulsion droplets in suspension in 
an aqueous bulk phase, thereby solubilizing the wall material 
polymers. An important parameter of the process was the 
respective proportions of these compounds. The impact of the 
oil + surfactant/wall material weight ratio on the micropar-
ticulate properties, morphology, and size distribution was International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 3 Scanning electron micrographs showing the influence of the wall material 
concentration on the microparticular size distribution and standard deviation. Wall 
material is gum arabic. concentrations are indicated on the pictures. scale bar 10 µm.
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Figure 2 size distribution values of maxima (curve peaks) and standard deviation of 
the samples presented in Figure 1, corresponding to the microparticles formulated 
with pure wall materials.
evaluated for the representative case of whey protein. The 
results are reported in Figure 5, and the quantitative study of 
the size maxima and standard deviation values are reported 
in Figure 6. Four different ratios were tested, ie, 1:1, 1:2, 
1:3, and 1:4, corresponding to vitamin E acetate loadings of 
37.5, 27.3, 21.4, and 17.6 wt%, respectively.
The samples appear to be very homogenous, generally 
presenting a similar aspect. When compared with the pure 
formulations shown in Figure 1A, the first point to observe 
is the almost perfect spherical shape of the particles. The 
“deflated” morphology of the particles discussed above is no 
longer present, now being replaced by spherical shapes and 
smooth surfaces. This could be due to the global increase of 
droplet loading before drying, which is doubled with the ratio 
1:1. Hence, the empty cavities formed with pure wall materi-
als no longer exist, giving way to spherical morphologies. 
As for the size distribution, a clear difference is observed 
between the ratios 1:1, 1:2, 1:3, and 1:4. The latter presents an 
outstanding submicronic size, with particle diameters around 
500 nm. Looking at this result in terms of interface properties, 
we can note that not only do the nanoemulsions here show 
significant surfactant properties, but that the droplet loading 
is reduced with the ratio of 1:4, thus affording a decrease in 
the particle size. Furthermore, these results were obtained 
with whey protein, for which each ratio gave rise to powdery 
and homogeneous samples. However, using the other wall 
materials, this limit fluctuated from 1:1 to 1:4. This parameter 
was accordingly fixed to 1:4 for the rest of the study.
The next series of experiments concerned the actual 
process of nanoemulsion microencapsulation. Wall materi-
als were spray-dried along with surfactant alone, vitamin E 
acetate alone, and both the surfactant and the vitamin E 
acetate formulated as a nanoemulsion. For each experiment 
using surfactant alone and vitamin E acetate alone, the com-
pound amounts strictly corresponded to those required for 
nanoemulsion formulation. The aim of these experiments was International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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surfactant  is  cremophor®,  oily  phase  is  vitamin  e  acetate.  The  hydrodynamic 
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to see whether the nanodispersed forms themselves could 
have an influence on the spray-drying process. The results 
are presented in Figure 7 for representative wall materials, 
including quantitative study of the size maxima and standard 
deviation values for gum arabic (Figure 7B), whey protein 
(Figure 7C), and Kleptose and Nutriose (Figure 7D), and are 
summarized in Figure 8.
Here, the first observation concerns the morphology of the 
microparticles as a function of the compounds added to the wall 
materials. As discussed earlier, the “deflated” aspect of the par-
ticles is generally inhibited by the presence of the oily phase or 
nanoemulsions, but, conversely, it seems to be enhanced by the 
surfactant (except with the whey protein for which this deflated 
effect appears less pronounced). The wall material + vitamin E 
acetate alone systems provide particularly smooth surfaces. This 
series of experiments also revealed interesting results as regards 
the formulation process itself. Indeed, for a similar amount of 
surfactants using the wall material + surfactant alone system and 
the wall material + nanoemulsion system, the resulting micropar-
ticle sizes were significantly different, especially for gum arabic 
and whey protein. However, even if this result is not as appar-
ent with Kleptose and Nutriose, the global trend highlighted in 
  Figure 8 shows that generally the size is slightly reduced with the 
wall material + surfactant alone system and slightly increased for 
the wall material + vitamin E acetate alone system.
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These results corroborate the idea that nanoformulated 
materials can present more enhanced effects than those 
induced by nonformulated compounds. In our case, only 
the surfactant is likely to affect the interface phenomena 
governing the spray-drying process. This can be illustrated 
by comparison of the wall material + surfactant alone system 
and the wall material + nanoemulsion system. This suggests 
that some of the nanoemulsion droplets are “trapped” at the 
water/air interface, reducing the surface tension even more 
than with the surfactant alone, and giving rise to smaller 
droplets.
Nanoemulsion release from  
the spray-dried microparticles
One objective of this study was to prove that it was possible to 
microencapsulate nanoemulsion droplets in order to propose 
new solutions for the delivery of nanoemulsions, thus allow-
ing enhanced absorption of the encapsulated compounds. 
The microencapsulation of nanoemulsion droplets also 
requires that, once entrapped in the dried microparticles, the 
nanoemulsion oil droplets conserve their size and individual 
nature. This can be checked by the redispersion of the dried 
powder in water. The polymer is rapidly solubilized due to the 
huge specific surface of the powder and, if kept intact during 
the process, the nanoemulsion droplets can be redispersed in 
water. This is exactly what occurred with all our samples of 
microparticles encapsulating nanoemulsions. Their resolubi-
lization in water allowed redispersion of the nanoemulsion 
droplets. Because all the wall materials used are soluble in 
water, the times within which the   nanoemulsions are redis-
persed in water appear to be relatively short, ie, a few minutes. 
They will depend on both the water/particle ratio and the nature 
of the wall materials (ie, on the kinetics of the wall material 
solubilization in water). For instance, for a given amount of 
powders mixed in water (10 wt%), redispersion of the nano-
emulsions was achieved for the different WM as follows: 
gum arabic about 5 minutes; whey protein about 5   minutes; 
Kleptose about 3 minutes; and Nutriose about 3 minutes. After 
redispersion, the samples, like typical   nanometric dispersions, 
were translucent and their   characterization was performed by International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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Table 1 Nanoemulsion size distribution, before mixing with wall materials (“raw nanoemulsions”), mixed with wall materials before 
spray-drying, and after spray-drying when the dried particles are resolubilized in the same water volume
Wall materials Raw  
nano-emulsion
Nano emulsion + WM before  
spray drying
Nano emulsion + WM  
after spray drying
dh (nm) PDI dh (nm) PDI dh(nm) PDI
Arabic gum
79.1 0.087
86.9 0.130 155.4 0.176
Maltodextrin 81.0 0.110 182.3 0.276
Modified starch 82.6 0.150 168.3 0.268
Whey protein 83.7 0.082 100.6 0.220
Lycoat® 86.9 0.148 171.3 0.252
Nutriose® 80.6 0.081 166.2 0.244
Kleptose® 98.3 0.054 127.9 0.142
Abbreviations: WM, wall materials; PDI, polydispersity index.
Spray-dried
microparticles
Matricial polymer
structure
PEGylate surfactants
Vitamin E acetate
~ 150 nm
~ 2 µm
Figure 9 schematic illustration of the spray-dried microparticles encapsulating vitamin e acetate nanoemulsions.
dynamic light scattering. The results are reported in Table 1, 
presenting the hydrodynamic diameter and polydispersity 
index of the nanoemulsion droplets, just after formulation 
(called “raw nanoemulsions”), after mixing with wall materi-
als before and after spray-drying, and redispersion in the same 
volume of water.
To summarize, a comparison of the samples before and 
after spray-drying showed a significant increase in size, and 
was generally doubled for all the samples. This results from 
slight droplet coalescence and can simply be due to turbu-
lence and heat during the spray-drying process. The results 
also vary in the function of the wall materials, again indicat-
ing that the oil/polymer interactions and affinities could play 
a role in droplet merging. Nevertheless, the average size of 
the redispersed droplets remained at about 150 nm and, with a 
polydispersity index of around 0.2, such a suspension can still 
rightly be considered a   nanoemulsion. The microencapsula-
tion of nanoemulsions thus appears to have been successful. 
Taking into account all the results of the present study, a 
schematic illustration of the microparticulate structure is 
shown in Figure 9. These multiscaled systems can in fact 
be used as carriers for nanoemulsions, ensuring their easy 
manipulation, concentration, and administration.
stability of vitamin e acetate  
in the spray-dried powders
Stability studies were performed on the powders, the results 
of which are reported in Figure 10. We can first note that, at 
initial time, the measurements show approximately 100% 
of vitamin E acetate for all the seven wall materials tested. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 10 high-performance liquid chromatography measurements monitoring the 
integrity of the encapsulated vitamin e acetate in the spray-dried powders over time.
This simply indicates that the spray-drying process does not 
destroy the encapsulated molecules. It is also worth noting 
that only one peak of vitamin E acetate was observed for all 
the wall materials studied and that no other peaks appeared 
over 3 months. In other words, there was no degradation of 
vitamin E acetate.
This result is confirmed and corroborated by the over-
all aspect of the curves in Figure 10, indicating a constant 
amount of vitamin E acetate with a recovery of approximately 
100%. These results confirm that the spray-drying process 
can be considered an efficient method for the microencapsula-
tion of nanoemulsions, ensuring the integrity of the molecules 
throughout the process, as well as their conservation during 
storage of the dried product.
Conclusion
This study proposes a novel technique using a spray-drying 
process to microencapsulate nanoemulsions. The dried 
powder obtained consists of multiscaled objects in the form 
of microparticles, with a size range of around 2 µm. The 
present study also demonstrates that these microparticles are 
able to encapsulate (or more precisely “entrap”) nanoemul-
sion droplets of around 150 nm in their polymeric matricial 
structure. The low-energy nanoemulsification method chosen, 
associated with the gentle form of spray-drying, makes the 
whole process suited to the encapsulation of sensitive mol-
ecules. The model lipophilic molecule tested was vitamin 
E acetate, encapsulated at around 20% in the dried powder. 
We show that the presence of nanoemulsion in the solutions 
before spray-drying can have a significant impact on the size 
distribution and morphology of the microparticles. However, 
the process itself does not destroy the oily nanodroplets, which 
can be easily redispersed once the powder is in contact with an 
aqueous phase. HPLC follow-up of vitamin E acetate integrity 
shows that the molecules remain intact throughout the process, 
as well as during their conservation in dried form.
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